Astragaloside IV against Alzheimer's disease via microglia-mediated neuroinflammation using network pharmacology and experimental validation-Reference-Cited by-同舟云学术

Astragaloside IV against Alzheimer's disease via microglia-mediated neuroinflammation using network pharmacology and experimental validation

Published:2023-10 Issue: Volume:957 Page:175992
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Bao MuLan^ORCID,Bade RenGui,Liu Hua,Tsambaa Battseren,Shao Guo,Borjigidai Almaz,Cheng Yong^ORCID

Publisher

Elsevier BV

Subject

Pharmacology

Reference74 articles.

1. STAT3 as a target for inducing apoptosis in solid and hematological tumors;Al Zaid Siddiquee;Cell Res.,2008

2. SQYZ granules, a traditional Chinese herbal, attenuate cognitive deficits in AD transgenic mice by modulating on multiple pathogenesis processes;An;Am. J. Transl. Res.,2018

3. Neuroinflammation, microglia and implications for retinal ganglion cell survival and axon regeneration in traumatic optic neuropathy;Au;Front. Immunol.,2022

4. jvenn: an interactive Venn diagram viewer;Bardou;BMC Bioinf.,2014

5. The JAK/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer's and Huntington's diseases;Ben Haim;J. Neurosci.: Official J. Society Neurosci.,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network pharmacology and experimental validation to reveal the pharmacological mechanisms of Astragaloside Ⅳ in treating intervertebral disc degeneration;European Journal of Pharmacology;2024-11

2. Jinmaitong alleviates diabetic neuropathic pain by inhibiting JAK2/STAT3 signaling in microglia of diabetic rats;Journal of Ethnopharmacology;2024-10

3. Noncoding RNAs as therapeutic targets in autophagy-related diabetic cardiomyopathy;Pathology - Research and Practice;2024-04